Surgical Treatment on Malignant Tumors of the Stomach

  • H. W. Schreiber
  • M. Rehner


Carcinoma of the stomach begins as a circumscribed lesion in the mucosal layer; it grows, produces metastases and will, without treatment, lead to death within 5, 5 months up to maximally 30 months after diagnosis (REMINE, PRIESTLEY, BERKSON, 1964). The speed of growth is usually irregular, but may be steady in an individual case. Clinical symptoms develop in a comparable manner: they begin with a so-called silent period which is then followed by indifferent symptoms; the latter will not become more distinct until the carcinoma is spreading. Therefore, the classical clinical diagnosis based on subjective discomfort, clinical symptoms and a positive histological diagnosis comes normally too late for every second patient. The treatment of choice is a radical partial or total resection of the stomach and the adjacent organs in so far as they are affected or endangered. The patient is cured if the entire tumor has been completely removed. For patients who have survived this operation for five years or more, the mortality risk is similar to that of the normal population. This statement based on clinical and surgical experience remains fundamental even though new immunologic and kybernetic models of carcinogenesis may arise and force us to modify our concepts.


Gastric Cancer Total Gastrectomy Partial Gastrectomy Macroscopic Type Early Gastric Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amgwerd,R., Hammer, B.: Der Magenkrebs. Bern: Huber 1972.Google Scholar
  2. Berndt,H.,Gummel,H.: Erfahrungen mit der Stadieneinteiling des Magenkrebses. Arch Geschwulstforschg. 30, 42 (1967).Google Scholar
  3. Boeckl, O .: Signifikante Faktoren für die Prognose des Magenkarzinoms. Langen- becks Arch.klin. Chir. 302, 653 (1963).CrossRefGoogle Scholar
  4. Gütgemann,A., Schreiber, H. W.: Das Magen- und Kardia-Kerzinom. Stuttgart: F.Enke 1964.Google Scholar
  5. Hayashida, T., Kidokoro, T.: End results of early gastric carcinoma. Adv.Abstr. Fourth World Congress of Gastroenterology Copenhagen 1970.Google Scholar
  6. Hegemann, G., Schaudig, H.: Ergebnisse bei der Behandlung des Magenkrebses. Dtsch. Med. Wschr. 91, 336 (1966).CrossRefGoogle Scholar
  7. Jojima, Y .: Study of early gastric carcinoma. Gastroenterological Endoscopy 11, 32 (1969).Google Scholar
  8. Oshima, H . : Das Frühkarzinom des Magens im Welt Schrifttum. Gastrokamera- Seminar Berlin 1969. Z.Gastroenterol. (Verhandlungsband) 4, 151 (1971)Google Scholar
  9. Oshima, H., Witt, H., Bürger, H.: Gastrokamera und Röntgendiagnostik. Berlin- New York: W. de Gruyter 1972.Google Scholar
  10. Remine, W. H., Priestley, J. T., Berkson, J.: Cancer of the Stomach. Philadelphia- London: W.B.Saunders 1964.Google Scholar
  11. Schreiber, H. W., Bartsch, W. M., Siedeck, M.: Serum ei weiß und Prognose beim Karzinom und Sarkom des Magens.Langenbecks Arch. klin. Chir. 307, 355 (1964).CrossRefGoogle Scholar
  12. Schreiber, H. W .: Radikalität und pathophysiologische Gesichtspunkte bei der Resektion des Magenkarzinoms. Langenbecks Arch. klin. Chir. 314, 213 (1966).CrossRefGoogle Scholar
  13. Schwaiger, M., van Lessen, H.: Grundsätzliches zur Therapie des Magenkarzinoms. Mü Wschr. 108, 297 (1966).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1974

Authors and Affiliations

  • H. W. Schreiber
    • 1
  • M. Rehner
    • 1
  1. 1.UniversitätsklinikHamburgGermany

Personalised recommendations